Apple Inc is evaluating DRAM memory chips from Chinese, state-backed producer ChangXin Memory Technologies (CXMT) for use in devices sold in China, according to people familiar with the matter. The technology company has also been active in discussions with U.S. authorities to seek wider permission for the deployment of CXMT parts, though it has not formally decided to adopt the components in commercial products.
The development highlights CXMT’s rapid ascent in the global memory market. The company has moved from heavy domestic subsidy support to become the fourth-largest DRAM manufacturer globally, behind Samsung Electronics, SK Hynix and Micron Technology.
Industry figures cited by those familiar with the situation put CXMT’s share of global DRAM wafer capacity at roughly 11% last year. That footprint is expected to grow to about 15% by 2028 as new production lines in Hefei, Shanghai and Beijing come online.
Longer-term, competitors are voicing concerns that continued state-backed investment could enable Chinese memory producers to replicate the rapid capacity buildouts seen in other industries, a dynamic that could ultimately exert downward pressure on global memory prices.
To support its expansion, CXMT is preparing a domestic initial public offering that analysts estimate could value the company at as much as 3 trillion yuan. The company plans to deploy IPO proceeds to expand manufacturing capacity, to develop next-generation DRAM technologies and to accelerate its move into high-bandwidth memory (HBM), which is used in AI accelerators.
Clear summary
Apple is testing CXMT-made DRAM for China-market devices and is engaging with U.S. regulators to broaden permitted use of the supplier’s chips, without yet committing to commercial adoption. CXMT has grown to become the fourth-largest global DRAM wafer producer, held roughly 11% of capacity last year with projections to reach 15% by 2028, and is planning a domestic IPO worth as much as 3 trillion yuan to fund capacity expansion, next-generation DRAM development and HBM efforts.
Key points
- Apple is evaluating CXMT DRAM for China-specific devices and is seeking regulatory leeway in the U.S., but has not committed to commercial use - this affects the consumer electronics supply chain and semiconductor procurement.
- CXMT has become the world’s fourth-largest DRAM wafer producer, with an estimated 11% global share last year and an expected rise to 15% by 2028 as new lines open in Hefei, Shanghai and Beijing - relevant to global memory capacity and suppliers.
- CXMT is preparing a domestic IPO potentially valuing the firm at up to 3 trillion yuan; proceeds are earmarked for capacity expansion, next-generation DRAM and HBM for AI accelerators - impacting capital markets and the AI infrastructure sector.
Risks and uncertainties
- Apple has not committed to using CXMT chips commercially, so final supply decisions and scale effects remain uncertain - this directly affects device supply chains.
- Outcomes of U.S. regulatory deliberations over broader use of CXMT products are unresolved, creating policy uncertainty for U.S. technology firms and cross-border procurement.
- Sustained state-backed capacity expansion by Chinese producers could put downward pressure on global memory prices, posing margin and competitive risks across the semiconductor sector.